Meitav Investment House’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-15,049
| Closed | -$2.04M | – | 274 |
|
2023
Q4 | $2.04M | Sell |
15,049
-279
| -2% | -$37.9K | 0.03% | 151 |
|
2023
Q3 | $1.9M | Sell |
15,328
-47
| -0.3% | -$5.81K | 0.03% | 161 |
|
2023
Q2 | $1.93M | Sell |
15,375
-102
| -0.7% | -$12.8K | 0.03% | 180 |
|
2023
Q1 | $2.03M | Sell |
15,477
-7,970
| -34% | -$1.05M | 0.04% | 178 |
|
2022
Q4 | $3.09M | Sell |
23,447
-113
| -0.5% | -$14.9K | 0.05% | 163 |
|
2022
Q3 | $2.77M | Sell |
23,560
-140
| -0.6% | -$16.5K | 0.05% | 175 |
|
2022
Q2 | $2.79M | Sell |
23,700
-7,020
| -23% | -$826K | 0.05% | 172 |
|
2022
Q1 | $4M | Sell |
30,720
-218
| -0.7% | -$28.4K | 0.06% | 175 |
|
2021
Q4 | $4.72M | Sell |
30,938
-160
| -0.5% | -$24.4K | 0.08% | 162 |
|
2021
Q3 | $5.03M | Sell |
31,098
-7,025
| -18% | -$1.14M | 0.08% | 157 |
|
2021
Q2 | $6.24M | Buy |
38,123
+6,728
| +21% | +$1.1M | 0.16% | 113 |
|
2021
Q1 | $4.73K | Buy |
31,395
+11,418
| +57% | +$1.72K | 0.13% | 124 |
|
2020
Q4 | $3.02M | Buy |
19,977
+2,231
| +13% | +$338K | 0.12% | 108 |
|
2020
Q3 | $2.4M | Buy |
17,746
+14,134
| +391% | +$1.91M | 0.12% | 102 |
|
2020
Q2 | $494K | Buy |
+3,612
| New | +$494K | 0.03% | 225 |
|
2020
Q1 | – | Sell |
-1,941
| Closed | -$234K | – | 411 |
|
2019
Q4 | $234K | Sell |
1,941
-4,109
| -68% | -$495K | 0.02% | 376 |
|
2019
Q3 | $609K | Sell |
6,050
-6,074
| -50% | -$611K | 0.04% | 220 |
|
2019
Q2 | $1.32M | Buy |
12,124
+320
| +3% | +$34.9K | 0.09% | 130 |
|
2019
Q1 | $1.32M | Buy |
11,804
+7,950
| +206% | +$888K | 0.07% | 156 |
|
2018
Q4 | $341K | Sell |
3,854
-4,564
| -54% | -$404K | 0.02% | 242 |
|
2018
Q3 | $1.02M | Sell |
8,418
-3,379
| -29% | -$410K | 0.05% | 207 |
|
2018
Q2 | $1.55M | Sell |
11,797
-68,502
| -85% | -$9.01M | 0.07% | 153 |
|
2018
Q1 | $8.57M | Sell |
80,299
-429,842
| -84% | -$45.9M | 0.44% | 61 |
|
2017
Q4 | $54.5M | Buy |
+510,141
| New | +$54.5M | 3.18% | 7 |
|